Three years after the FDA OK'd Purdue Pharma's reformulated version of its controlled-release oxycodone drug, OxyContin, the company won the coveted "abuse-deterrent" language in the medicine’s labeling.
"This is the first time we have approved such language in opioid drug labeling, and we made this determination after...





